Bardin Hill Management Partners’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-177,016
Closed -$1.78M 75
2022
Q4
$1.78M Hold
177,016
0.39% 38
2022
Q3
$1.74M Hold
177,016
0.4% 36
2022
Q2
$1.73M Buy
+177,016
New +$1.73M 0.45% 34

Other funds holding AONC

Bardin Hill Management Partners's AONC Position: Q1 2023 in Review

Bardin Hill Management Partners sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 177,016 shares — an estimated $1.78M sold.

Bardin Hill Management Partners first reported a position in AONC in Q2 2022 and held it in 3 quarters. The position peaked at $1.78M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Bardin Hill Management Partners reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bardin Hill Management Partners sold 177,016 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.78M.
  • Bardin Hill Management Partners first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2022 and held it in 3 quarters.
  • Bardin Hill Management Partners's American Oncology Network, Inc. Class A Common Stock position peaked at $1.78M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Bardin Hill Management Partners's 13F filing for Q1 2023, filed 12 May 2023.